Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sounds to me like the Quiet Period may be ending.
News!!
Share Share
Tweet Tweet
Forward Forward
Progressive Care Announces Shareholder Conference Call and Business Update on November 14, 2022
Open web version
MIAMI, November 8, 2022 - Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company (the “Company” or “Progressive Care”), is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Monday, November 14th, 2022.
Co-vice chairman and CEO, Alan Jay Weisberg, stated, “It has been an exciting quarter for the company and we are really looking forward to sharing developments with our shareholders.”
Those attending the investor conference call will have the opportunity to submit questions concerning the Company to Stuart Smith of SmallCapVoice.Com, Inc. via e-mail: ssmith@smallcapvoice.com by 12:00 PM EST on Friday, November 11th, 2022. The Company plans to address as many appropriate questions as possible.
To access the call:
Dial-In Number: 1-857-232-0157
Access Code: 422095
For those unable to participate in the live conference call, a replay will be available at https://www.smallcapvoice.com/clients/rxmd/. shortly after the call has concluded.
An archived version of the webcast will also be available at https://progressivecareus.com/news-releases/.
Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.progressivecareus.com/
PharmcoRx
https://www.pharmcorx.com/
ClearMetrX
https://www.clearmetrx.com/
Forward-Looking Statements:
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
?
Find Out More
Facebook
Twitter
Link
Website
Copyright © 2022 Progressive Care, All rights reserved.
You are receiving this email because you opted in via our website.
Our mailing address is:
Progressive Care
901 North Miami Beach Blvd
Suite 1 and 2
North Miami Beach, FL 33162
Add us to your address book
Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.
Email Marketing Powered by Mailchimp
No more Illiad, thank goodness ??!
Jay’s filing just showed up. Slow SEC.
Filing: SEC.report/Document/0001493152-22-030723/
Form 4 has been filed by:
: Weisberg Alan Jay
: Weisberg Alan Jay
Security Sale/Purchase Record accepted on 2022-11-04 00:00:00
You received this notification because an SEC filing has was made in the EDGAR system matching a company you subscribed to notifications for.
Manage your company subscriptions, notification level, or unsubscribe at https://sec.report/notifications.php
Click here to unsubscribe from all emails ever.
SPAC Sponsors That ‘Piled In’ During Boom May Face $4 Billion Tab
Blank-check sponsors that jumped on the bandwagon to cash in on the SPAC boom may be stuck with a roughly $4 billion bill as they close up shop and return money to investors. That’s on top of the estimated $352 million they’ve already lost this year.
The SPAC craze was a goldmine for sponsors like “SPAC King” Chamath Palihapitiya and Howard Lutnick. They were early to the game and benefited from a bull market that bolstered the industry with investors eager to pay large premiums for a pile of cash. Now that the bubble has burst, sponsors who “piled in during the boom in 2021” could lose billions, according to Jay Ritter, professor of finance at the University of Florida.
Sponsors on average could lose about $8 million of at-risk capital -- mostly fees for underwriters and others -- on each liquidation, Ritter says. With 646 active SPACs either hunting for targets or pushing to complete them, and an average of roughly eight deals completed a month this year, he expects more than 80% of SPACs will need to close down.
That would result in losses of about $4.1 billion across the failed ventures. But that number may be closer to $5 billion given most recent SPACs essentially paid investors extra for buying into the initial public offering, Ritter says.
“A lot of these fairly sophisticated financial professionals were a bit guilty of chasing past returns,” Ritter said by phone. “Six months from now it might be worthwhile for a sponsor to take a SPAC public, but I’ve been scratching my head for the past 18 months over the rush to spend $8 million to get into an incredibly competitive market.”
So far this year, 44 SPACs have closed and returned the billions they raised to investors, compared to just one over the same period in 2021. Dozens more are working to close up shop before the end of the year.
Alec Gores, one of the most well-respected sponsors, said Thursday that three of his SPACs, which raised a combined $1.3 billion last year, want to shutter soon. While the firm is “committed to the SPAC product in the long-term,” it acknowledged the “current reset in the SPAC market is necessary in light of the activity over the past two years,” Gores said in a statement.
Read more: Gores Aims to Shutter Trio of SPACs Early as Industry Resets
The issues for SPACs include a closed window for traditional IPOs and a battered economy, as well as pressures from US regulators. Before the boom days resulted in more than 800 new SPACs in a two-year period, the market had presented a niche opportunity for companies that wanted to go public without some of the caveats of an IPO.
That turned upside down when stuck-at-home retail traders flush with cash and Wall Street pros looking to turn a quick profit took them mainstream.
Bubble Gets Burst
“This is bubble activity,” says Enrique Abeyta, of the billions in looming sponsor losses. Abeyta follows SPACs as editor of Empire Financial Research. “The vast majority of these SPACs are going to not do anything,” he said.
The fallout from failed efforts has hit experienced teams, those with little to no SPAC experience and the countless firms that tied their hopes to celebrities and athletes. Both Palihapitiya and Bill Foley have given up one two SPACs recently. Financier Patrick Orlando is clamoring to close the deal between Digital World Acquisition Corp. and Donald Trump’s media venture to avoid a third failed venture.
To be sure, many sponsors in the early days reaped massive benefits from their ventures. For the 284 SPACs that completed deals or closed from 2015 to September 2021, sponsors had an average net payoff of at least $46 million, according to a paper from Ritter and Minmo Gahng and Donghang Zhang. That means their total profits over that stretch were about $13 billion.
“Kind of like real estate investors in 2001-2008,” those who got in early did “very well on average,” while the group that was late to the party lost money, says Ritter.
To contact the reporter on this story:?Bailey Lipschultz in New York at blipschultz@bloomberg.net
To contact the editors responsible for this story:?Eric J. Weiner at eweiner12@bloomberg.net?Rheaa Rao
More Like This:
Beyond the Bell 10/21/22
Oct. 21, 2022
Lisa's Market Movers
Nov. 4, 2022
Getting Close to Bond Bull Market: Ameriprise Financial's Daoud
Oct. 21, 2022
The best of Bloomberg Business, delivered daily.?Subscribe to the Bloomberg Business Newsletter
I just may join them. We should be back into the.05s in the next few weeks.
There also might be a massive dump just before closing if that’s Iliad’s last day. If they have any shares left.
Got it.
Insider activity!!
Filing: SEC.report/Document/0001493152-22-030163/
Form 4 has been filed by:
: NORKUTE BIRUTE
: NORKUTE BIRUTE
Security Sale/Purchase Record accepted on 2022-11-02 00:00:00
You received this notification because an SEC filing has was made in the EDGAR system matching a company you subscribed to notifications for.
Manage your company subscriptions, notification level, or unsubscribe at https://sec.report/notifications.php
Click here to unsubscribe from all emails ever.
Today’s news !
Share Share
Tweet Tweet
Forward Forward
Progressive Care Launches Native Remote Patient Monitoring Mobile App and Physician Portal to Remotely Manage Chronic and Transitional Care
Open web version
MIAMI, FL – November 1, 2022 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce the launch of Remote Patient Monitoring (“RPM”) PharmcoMyRPM, a mobile app and patient portal, and PharmcoRPM, a web portal to help providers remotely manage patients’ chronic disease and transitional care.
The Company has successfully completed the integration of the PharmcoMyRPM patient portal and the PharmcoRPM physician portal, which includes a web platform and a native application available on the AppStore and Google Play. These portals allow staff of PharmcoRx, a subsidiary of Progressive Care, to connect patients to the Company’s new line of 5 G-powered devices to remotely monitor patients’ blood pressure, heart rate, weight, blood glucose, and oxygen saturation in real-time. Physicians will also have the option to integrate 99% of existing wearable devices including Apple Health, Garmin, and Fitbit for broader patient monitoring needs.
In addition to remote patient monitoring, the PharmcoRPM physician portal allows the Company to provide Chronic Care Management monitoring services, generate billing reports based on time spent providing care, and connect directly with patients to analyze their progress.
“We want to improve communication between patients and providers in an environment that promotes patient-centered care. The platform provides a list of care tasks designed to incentivize patients to be more active while recording their progress through our connected devices” stated Carlos Rangel, Head of Digital Transformation for PharmcoRx Pharmacy.
According to new research from MarketsandMarkets, the global RPM market is projected to reach $175.2 billion by 2027, growing at a robust 27% compound annual growth rate over the next 5 years. The National Center for Biotechnology Information estimates that approximately 67% of Medicare beneficiaries have two or more chronic conditions accounting for 94% of Medicare spending. The Company’s experience in medication and therapy management and its active participation in data analytics would carry over directly into the RPM marketplace. Through its own analysis, the Company has identified a number of patients it is currently servicing as candidates for RPM services and plans to begin working with physicians toward their enrollment into remote patient monitoring. The Company is estimating the ability to generate gross billings of around $120 per eligible Medicare patient per month for RPM and approximately $100 per month for eligible Medicare patients qualifying for CCM (Chronic Care Management).
“Our RPM platform launch is a major step forward for our Company. We believe our existing patient and physician base will greatly benefit from these tools in their effort to achieve positive outcomes. Making informed decisions based on reliable real-time data is key for doctors to operate in the most effective and efficient ways. Progressive Care has differentiated itself from competitors in terms of its commitment to medication therapy and adherence management. Our reputation among healthcare professionals in this domain is one of our strongest advantages,” stated Alan Jay Weisberg, CEO of Progressive Care.
For more information about Progressive Care, please visit the company’s website. Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.progressivecareus.com
PharmcoRx Pharmacy
https://www.pharmcorx.com
ClearMetrX
https://www.clearmetrx.com
Forward-Looking Statements:
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
Find Out More
Facebook
Twitter
Link
Website
Copyright © 2022 Progressive Care, All rights reserved.
You are receiving this email because you opted in via our website.
Our mailing address is:
Progressive Care
901 North Miami Beach Blvd
Suite 1 and 2
North Miami Beach, FL 33162
Add us to your address book
Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.
Email Marketing Powered by Mailchimp
I wonder who the privately held company is in this mixture of entities, according to the the definition.
I think this is one more piece of the SPAC puzzle that’s being put together.
am Subsidiary, National Storm Recovery, Expands Into Additional Wood Recycling Facility
-Signs Lease Agreement for 10 acres of Industrial Land in Ocoee, FL-
-Currently Collecting Hurricane Ian Debris for Conversion into Leading Soil Moisture Products, HumiSoil® and XLR8 Bio®, using Patented VRM Biologik Technology-
NEW YORK, NY, Oct. 24, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – The Sustainable Green Team LTD (OTCMKTS: SGTM), an industry-leading wholesale manufacturer and supplier of consumer and industrial wood-based mulch, soil, and lumber products nationwide, today announced that its subsidiary, National Storm Recovery, has signed a 5-year lease agreement for approximately 10 acres of industrial land in Ocoee, FL. National Storm Recovery will utilize the site for an additional wood recycling facility. The property has also been used for wood waste recycling for the last ten years.
This facility’s services are intended to support the City of Ocoee, Orange County, Florida and the State of Florida by providing a temporary storm debris and staging site for disaster-related contractors and for the collection and short-term storage of landscape and tree debris as part of any disaster recovery efforts. SGTM will also be utilizing VRM BioLogik’s Groundswell Continuous Fermentation process to produce soil treatment products that rebuild soil hydration on a cellular level from the collected vegetative and wood waste. SGTM recently signed a partnership agreement with Australia-based VRM Biologik Group, that will bring VRM’s world-leading soil moisture technology, HumiSoil® and XLR8 Bio®, to the United States.
VRM Biologik’s technology uses any vegetative green waste or compostable material, including wood material such as sawdust or chips or grindings from wood material, and applies a catalyst to stimulate natural reactions that manufactures and stores soil moisture. The 100-percent organic material is converted into HumiSoil®, a valuable soil amendment, reducing the need for fertilizers and chemicals while increasing production of agricultural products, including livestock grazing on pastureland.
Tony Raynor, founder, president, and CEO of The Sustainable Green Team, commented, “The timing of our National Storm Recovery subsidiary leasing this new wood recycling facility couldn’t be better coming less than one month after Hurricane Ian hit and our recent partnership with VRM Biologik was announced. Hurricane Ian turned out to be a top 5 U.S. storm and may have caused as much as $67 billion in damage in Florida.”
“With that level of damage, Hurricane Ian deposited millions of tons of organic material in Florida and waste facilities are groaning under the additional load. Our recent partnership with VRM was especially advantageous as we are now working together to help collect the storm debris and process it using the exclusive VRM Biologik technology that enables wholesale gas emissions to be avoided and instead become a resource for depleted soils in the form of VRM’s world-leading soil moisture technology, HumiSoil® and XLR8 Bio®,” concluded Mr. Raynor.
About Sustainable Green Team Ltd. (SGTM)
The Sustainable Green Team Ltd. (the “Company”) is a wholesale manufacturer and supplier of wood-based mulch, soil, and lumber products, selling directly to mass merchandisers, home centers, hardware stores, nurseries, garden centers, convenience stores, food stores and drug stores, in addition to wholesalers and distributors. The Company also provides arbor care and storm recovery services at the residential, commercial, and municipal levels while offering green waste solutions to large and small scale waste disposal and recycling companies located throughout the southeastern United States. The Company’s subsidiary, Mulch Manufacturing Inc., is the largest provider of cypress mulch in the country.
The Company has entered into an agreement with Australia-based VRM Biologik Group to bring VRM’s world-leading soil moisture technology to the U.S. at scale. HumiSoil® and XLR8 Bio® are soil treatment products that rebuild soil hydration on a cellular level, improving the soil and the vegetation and agricultural products it supports.
The Company will make HumiSoil® and XLR8 Bio® available for home gardens and lawns throughout the U.S. to help relieve water use in cities and also to help VRM Biologik Group in its mission to restore productivity in depleted topsoil in 25 percent of the world’s arable land.
About VRM Biologik Inc.
VRM Biologik Inc. holds exclusive rights for management and deployment of intellectual property of the VRM Biologik Group in the USA. VRM Biologik has innovated many methods and products to enhance photosynthesis and hydrogen management in soils and water. This includes the revolutionary deployment of catalysts which stimulate Biological Hydrosynthesis – a natural reaction which captures atmospheric carbon and results in the manufacture of additional water – in depleted and dry soils. The VRM Biologik Group is headquartered in Queensland, Australia and operates regenerative programs across Asia, Africa, and the
Graphs show the 50 MDA crossing the 200 MDA. Another bullish signal.
sgtm-logo-flat-green copy.png
Meet the Team
?
News
SGTM Press Release
?Throughout modern history, the harvest, treatment, and processing of wood has resulted in massive amounts of timber waste which largely includes debris being sent to landfills and disposal sites. Sustainable Green Team’s goal is to reduce the massive environmental burden on such sites via cutting edge and sustainable environmental services, products, and solutions that convert waste biomass into marketable environmentally conscious products.
No worries Bass, I’m holding 2 million shares and ready to add more.
RXMD up 40% over 3 weeks and 50 MDA will cross the 200 Moving Day Average next week. That indicates very bullish activity.
There’s 400,000 potential new patients for RXMD to solicit.
Military health care program to drop nearly 15,000 pharmacies from network
TRICARE, the health care program for active-duty service members, military retirees, reservists and their families, will drop more than a quarter of the pharmacies in its current network later this month, a move that will force an estimated 400,000 beneficiaries to find new pharmacies.
The program said nearly 15,000 independent, community pharmacies will no longer be in the TRICARE network as of October 24. The network will still include more than 40,000 pharmacies across the country.
FAMILY OF FALLEN NAVY SEAL CANDIDATE REMEMBERS KYLE MULLEN'S 'SEEMINGLY ENDLESS IMPACT ON THIS WORLD'
Military members and their families were notified about the drop in coverage last month. The Military Officers Association of America (MOAA) said military families in rural areas will be most affected by the change, especially those already affected when Walmart/Sam's Club left the TRICARE network last year.
MOAA estimaetd that nearly 400,000 beneficiaries will now need to find other pharmacies as a result of the change, which is about 4% of the TRICARE-eligible population.
Pentagon spokesman Charlie Dietz said TRICARE will continue to "meet or exceed" its standards for pharmacy access.
"Beneficiaries will continue to have many convenient, local in-network options for filling their medications, including those beneficiaries in rural locations," he said. "Nearly 95 percent of beneficiaries will maintain access to at least two network pharmacies within 15 minutes from their home, and 99.8 percent will have access within 30 minutes."
The decision to drop smaller pharmacies from the network came after Express Scripts, TRICARE's pharmacy contractor, cut pharmacy reimbursement rates to the point where it became "impossible for many independent community pharmacies to participate in the TRICARE pharmacy network," according to the National Community Pharmacists Association.
TWO AMERICANS DEAD IN UKRAINE, OFFICIALS SAY
CLICK HERE TO GET THE FOX NEWS APP
The group urged its members to sign onto a letter in late September asking why the program is making it harder for beneficiaries to access pharmacy services. The group said the actions of Express Scripts are "taking away pharmacy choice and creating disruptions for TRICARE beneficiaries and their caregivers and making it more difficult for many to access their necessary prescriptions."
Patrick Hauf is a politics writer for Fox News Digital.
This material may not be published, broadcast, rewritten, or redistributed.
©2022FOX News Network, LLC. All rights reserved.
More news!
New to The Street Announces its Five Business Guest Interviews on Episode #395, Airing on Bloomberg TV as a Sponsored Program, Tonight, October 13, 2022 at 9:30 PM PT
NEW YORK, Oct. 13, 2022 (GLOBE NEWSWIRE) -- FMW Media’s New to The Street announces the broadcasting of its business show broadcasting as a sponsored program on Bloomberg TV, October 13, 2022, at 9:30 PM PT.??
New to The Street’s TV show will air the following five (5) business interviews:
1). PetVivo Holdings, Inc.’s (NASDAQ: PETV) (NASDAQ: PETVW) ($PETV) interview with John Lai, CEO & President.
2). Mikra Cellular Sciences’ (a division of Lifeist Wellness, Inc.) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF) interview with Faraaz Jamal, CEO, Mikra Cellular Sciences & COO, Lifeist Wellness, Inc.
3). Sekur Private Data, Ltd.’s (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) interview with Mr. Alain Ghiai, CEO.
4). The Sustainable Green Team’s (OTC: SGTM) ($SGTM) interviews with Tony Raynor, CEO, and Brian Rivera, Administrative Assistant.
5). Tonix Pharmaceuticals, Inc.’s (NASDAQ: TNXP) ($TNXP) interview with Dr. Seth Lederman, MD, and CEO.
Episode #395
New to The Street TV is airing the Nasdaq Marketplace studio interview with John Lai, CEO / President PetVivo Holdings, Inc. (NASDAQ: PETV) (NASDAQ: PETVW) ($PETV). The Company is a biomedical device company that manufactures, commercializes, and licenses innovative medical devices and therapeutics for companion animals. Talking with TV Host Jane King, John gives viewers an update on the recent launch of the distribution agreement between PETV and MWI Animal Health (MWI), a leading animal health products and services distributor, and Amerisource Bergen subsidiary. With over $5B in annual revenue, MWI is one of the largest distributors of veterinary drugs and products, with lots of business resources and skilled personnel. Securos is the educational division at MWI, which provides hands-on-training, resources, and continuing education for veterinarians, helping them understand the full benefits of products. The educational and sales/ market teams at MWI now promote and distribute PETV’s injectable patented Spryng with OsteoCushion Technology that treats osteoarthritis and joint afflictions for dogs, horses, and cats. As a naturally derived product, Spryng mimics collagen tissue that significantly improves animals’ afflicted joints. The feline osteoarthritis version of Spryng is coming to market soon. John says the Spryng roll-out with MWI is going very well. Recently, PETV hired more seasoned personnel with over two decades of sales/marketing experience in the pet industry. The on-screen QR code is available during the show; download or visit PetVivo Holdings, Inc. - https://petvivo.com/ and Spryng with OsteoCushion Technology - https://www.sprynghealth.com/.
New to The Street airs TV Host Jane King’s Nasdaq Marketplace interview with Faraaz Jamal, CEO of Mikra Cellular Sciences ("Mikra") and COO of Lifeist Wellness, Inc. (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF). Faraaz provides viewers with an update Mikra's operations and on its CELLF™ product that enhances humans' microscopic cellular activities. Demand is up as product acceptance continues, gaining more customers, and Mikra continues to increase production output to meet this demand. Faraaz talks about clinical studies on CELLF with data suggesting that the nutraceutical can offset the issues associated with Chronic Fatigue Syndrome (CFS), known as "Brain Fog.” Many with long-Covid afflictions complain about "Brain Fog," with many physicians not understanding the best way to treat the problem. CELLF is a product with high concentrations of organic minerals and vitamins that target cellular activities through Mikra's novel cellular delivery system. CELLF is a nutraceutical gel with a buttery-type consistency, produced in small batches to ensure quality control standards that eliminate oxidation issues common with competitor products. Determined to change health care practices, which account for treatments after illness onset, Faraaz believes preventative products like CELLF can produce long-lasting good health. More products are in the Mikra pipeline, one of which is soon to come to market, an athletic product designed to increase workouts and decrease recovery times from solid performances. If you wake up after 8 hours of sleep feeling sluggish and seem to lose energy midday, CELLF could be the answer. Mikra sells its product through its e-commerce outlets. Mikra Cellular Sciences is a Lifeist Wellness, Inc. subsidiary that develops, produces, and sells bioactive consumer products. The on-screen QR code is available during the show; download or visit Mikra Cellular Sciences - https://wearemikra.com/.
On the New to The Street show, Alain Ghiai, CEO, Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) ($SWISF) (Sekur®), gives TV Host Jane King and viewers an overview of Sekur Private Data, Ltd.'s Sekur® cybersecurity products and talks about hacking problems coming out of North Korea. The North Koreans are attacking LinkedIn with posts full of malware to steal data. You think you are getting a business referral, so you hit the link, and your device becomes compromised. Years ago, open-source platforms allowed software developers to share code creating usable solutions to grow the reaches of technology. It was an acceptable method at the time, but now, open-source platforms, the majority used by "Big Tech," are where stolen code gets manipulated; favorite ways for hackers to create a nefarious campaign to steal data. Be careful about all those supposed "Free-Apps"; a virus code is waiting to infect your devices. Sekur is a closed-loop platform with an encryption layer of security not available using open-platform products. SekurMail and SekurMessenger, along with its other cybersecurity products, Sekur can offer its end-users a complete privacy solution. Because Sekur operates on a closed-source platform, code is unavailable for hackers to manipulate. Many understand the benefits of subscribing to Sekur's software solutions, which shows in the Company's financial results. Alian expects financial results in Q3 to be higher than Q2 from the increases in subscribers for its email, text, and other encrypted platforms. The Company lowered marketing expenses, and management believes its Q4 results should continue to be strong from subscriber increases. The Fundamental Research Report (FRC Report), dated September 8, 2022, provides a comprehensive report about the Company's current and future operational status. Sekur entered into a number of partnerships and the results from these agreements should show in financial results in Q1 2023. Alain sees more upside growth in 2023 and anticipates net profitability in 2025. Sekur Private Data, Ltd. hosts its services in Switzerland, benefiting from the stringent Swiss Privacy laws. It uses a closed-source proprietary technology on an independent and military-grade encrypted platform. The on-screen QR code is available during the show; download or visit Sekur Private Data, Ltd. – https://www.sekurprivatedata.com/ and http://www.Sekur.com. Peer to peer, end to end, secure suite, password manager, mail txt and video conference secure.
New to the Street's TV Host Jane King interviews The Sustainable Green Team’s (OTC: SGTM) Tony Raynor, CEO, and Brian Rivera, Administrative Assistant. From the Nasdaq Marketplace studio, Tony explains the Company's business in providing eco-friendly and sustainable solutions for several industries. As a holding Company with many wholly-owned subsidiaries, SGTM can develop and deploy innovative solutions to mitigate waste and other byproducts. For 35 years, one of SGTM's subsidiaries was the first to take naturally occurring iron oxide pigments and formulate colored mulch products. Other sustainable solutions and products continue at SGTM multiple locations because of its management's strong leadership and dedicated team. SGTM successfully works with municipalities in arbor culture and storm recovery, creating comprehensive waste solutions. From the abundance of green waste worldwide, SGTM can handle the waste making it into usable and friendly products. SGTM creates soils, mulches, and lumber products from green reusable waste. Brian talks about all the excitement coming from within the Company, its subsidiaries, and from external sources in creating and utilizing eco-friendly solutions and products. People just want to get involved in restoring and creating a green world. Cutting-edge technologies are from the visionaries who are pioneering new solutions to create cleaner outcomes for the planet. The Company entered into collaboration with an Australian company, VRM BioLogik Group which developed a product that creates water from organics. SGTM’s management will continue to aggressively seek partnerships with like-minded individuals and entities to find more environmentally sustainable solutions and products. The on-screen QR code is available during the show; download or visit The Sustainable Green Team - https://www.thesustainablegreenteam.com/.
Dr. Seth Lederman, MD, CEO of Tonix Pharmaceuticals, Inc. (NASDAQ: TNXP) ($TNXP), is at the Nasdaq Marketplace studio, talking with New to The Street's TV Host Jane King. As a clinical-stage biopharmaceutical Company, Seth informs viewers that the FDA approved an IND clearance for TNX-601 for human depression. The Company is developing a time-released pill, a once-a-day dose, as a new first-line potential treatment for those inflicted with depression. The pill's formulation uses the compound tianeptine. Europe, Latin America, and Asia countries for about 30-years used this compound to treat those depressed. TNXP anticipates moving TNX-601's IND stage forward to a Phase 2 trial sometime beginning of next year, 2023. Tonix has many pipeline drugs in development. Its led product TNX-102 SL completed its first part of the Fibromyalgia FDA Phase 3 clinical trial and is moving forward with the all the necessary FDA rules expecting to achieve a new drug approval status. Two-thirds of Long-Covid patients have multi-site pain, similar to those who have Fibromyalgia. Tonix is moving forward with an FDA Phase 2 Long-Covid prevail study for its TNX-102 SL. Also, those with Chronic Fatigue Syndrome (CFS) could use TNX-102SL if approved to treat accordingly. Tonix Pharmaceuticals is developing many drugs to treat central nervous system disorders and diseases. The on-screen QR code is available during the show; download or visit Tonix Pharmaceuticals, Inc. - https://www.tonixpharma.com/.
About PetVivo Holdings, Inc. (NASDAQ: PETV) (NASDAQ: PETVW) ($PETV):
PetVivo Holdings Inc. (NASDAQ: PETV) (NASDAQ: PETVW) ($PETV) is an emerging biomedical device company focused on manufacturing, commercializing, and licensing innovative medical devices and therapeutics for companion animals. The Company’s strategy is to leverage human therapies for treating companion animals cost-effectively and time-efficiently. A vital component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than more stringently regulated pharmaceuticals and biologics. PetVivo has a pipeline of seventeen products for the treatment of animals and people. A portfolio of nineteen patents protects the Company’s biomaterials, products, production processes, and methods of use. The Company’s lead product SPRYNG™ with OsteoCushion™ technology, a veterinarian-administered, intraarticular injection for the management of lameness and other joint-related afflictions, including osteoarthritis, in dogs and horses, is currently available for commercial sale - https://petvivo.com/.
About Mikra Cellular Sciences:
Mikra Cellular Sciences ("Mikra"), a division of Lifeist Wellness, Inc. (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF), is a breakthrough Company seeking to unlock cellular potential and maximize the health of humans. Mikra intends to bridge the scientific gap between cellular health and consumer wellness and focuses on ones’ health at the cellular level. Human cells are responsible for the overall functionality of human biology. Mikra continues to develop products that can enhance cellular absorption of key and need minerals and nutrients to improve health and wellness. CELLF™ product is clinically tested and engineered to bring balance to the body and mind on a cellular level -https://wearemikra.com/. Lifeist Wellness, Inc. (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF) is sitting at the forefront of a post-pandemic wellness revolution, leveraging the advancements in science and technology to build breakthrough companies that transform human wellness. Its business portfolio includes: CannMart, a B2B wholesale distribution business that facilitates recreational cannabis sales to Canadian provincial government control boards; CannMart Labs, a BHO extraction facility for the production of high-margin cannabis 2.0 products; the CannMart.com marketplace, which provides US customers with access to hemp-derived CBD and smoking accessories; Australian Vapes, the country's largest online retailer of vaporizers and accessories; Findify, a leading AI-powered search-and-discovery platform; and Mikra, a biosciences and consumer wellness company seeking to develop innovative therapies for cellular health. Information on Lifeist and its businesses - www.lifeist.com, www.cannmart.com, www.australianvaporizers.com.au, www.wearemikra.com, and email: ir@lifeist.com.
About Sekur Private Data Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0):
Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) is a cybersecurity and internet privacy provider of Swiss-hosted solutions for secure communications and secure data management. The Company distributes encrypted emails, secure messengers, secure communication tools, secure cloud-based storage, disaster recovery, and document management products. The Company sells and serves consumers, businesses, and governments worldwide through approved wholesalers, distributors, and telecommunications companies. Contact Sekur Private Data, Ltd. at corporate@globexdatagroup.com or visit https://www.sekurprivatedata.com and https://www.sekur.com.
About The Sustainable Green Team, Ltd. (OTC: SGTM) ($SGTM)
The Sustainable Green Team, Ltd. (OTC: SGTM) ($SGTM) is an emerging provider of environmentally beneficial solutions for preserving natural resources and the municipal waste and recycling industries. The Company is a wholesale manufacturer and supplier of wood-based mulch and lumber products, primarily in the Midwest, Southeast, and Ohio Valley regions. The Company also provides arbor care and storm recovery services to municipalities, corporations, and consumers, primarily in the southeastern United States. The Company plans to expand its operations through organic growth and strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified. The Company’s customers include governmental, residential and commercial clients - https://www.thesustainablegreenteam.com/
About Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) ($TNXP):
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) ($TNXP) is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring, and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. Tonix’s portfolio comprises immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. Tonix’s immunology portfolio includes biologics to address organ transplant rejection, autoimmunity, and cancer. TNX-15001 is a humanized monoclonal antibody targeting CD40-ligand in development to prevent allograft and xenograft rejection and treat autoimmune diseases. A Phase 1 study of TNX-1500 is expected to be initiated in the second half of 2022. Tonix’s rare disease portfolio includes TNX-29002 for the treatment of Prader-Willi syndrome. The FDA has granted TNX-2900 Orphan-Drug Designation. Tonix’s infectious disease pipeline consists of a vaccine in development to prevent smallpox and Monkeypox called TNX-8013, next-generation vaccines to prevent COVID-19, and an antiviral to treat COVID-19. Tonix’s lead vaccine candidates for COVID-19 are TNX-1840 and TNX-18504, live virus vaccines based on Tonix’s recombinant pox vaccine (RPV) platform. TNX-35005 (sangivamycin, i.v. solution) is a small molecule antiviral drug to treat acute COVID-19 and is in the pre-IND stage of development. TNX-102 SL, (cyclobenzaprine HCl sublingual tablets) is a small molecule drug being developed to treat Long COVID, a chronic post-acute COVID-19 condition. Tonix expects to initiate a Phase 2 study in Long COVID in the second quarter of 2022. The Company’s CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. Tonix’s lead CNS candidate, TNX-102 SL, is in mid-Phase 3 development to manage fibromyalgia, with a new Phase 3 study launched in the second quarter of 2022. Finally, TNX-13006 is a biologic designed to treat cocaine intoxication that is expected to start a Phase 2 trial in the second quarter of 2022 - https://www.tonixpharma.com. (1TNX-1500 is an investigational new biologic at the pre-IND stage of development and has not been approved for any indication.2TNX-2900 is an investigational new drug at the pre-IND stage of development and has not been approved for any indication.3TNX-801 is a live horsepox virus vaccine for percutaneous administration in development to protect against smallpox and Monkeypox. TNX-801 is an investigational new biologic and has not been approved for any indication.4TNX-1840 and TNX-1850 are live horsepox virus vaccines for percutaneous administration, in development to protect against COVID-19. TNX-1840 and TNX-1850 are designed to express the SARS-CoV-2 spike protein from the omicron and BA.2 variants, respectively. TNX-1840 and TNX-1850 are investigational new biologics at the pre-IND stage of development and have not been approved for any indication. 5TNX-3500 is an investigational new drug at the pre-IND stage of development and has not been approved for any indication.6TNX-1300 is an investigational new biologic and has not been approved for any indication.)
About FMW Media:
FMW Media operates one of the longest-running US and International sponsored and Syndicated Nielsen Rated programming television brands, "New to The Street," and its blockchain show, "Exploring The Block." Since 2009, these brands have run biographical interview segment shows across major U.S. television networks. The paid-for-television programming platforms can potentially reach over 540 million homes in the US and international markets. FMW's New to The Street / Newsmax televised broadcasting platform airs its syndication on Sundays at 10 -11 AM ET. FMW is also one of the nation's largest buyers of linear television, long and short-form paid programming - https://www.newsmaxtv.com/Shows/New-to-the-Street & https://www.newtothestreet.com/.
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology. However, not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at which such performance or results are achieved. This press release should be considered in all filings of the Companies contained in the Edgar Archives of the Securities and Exchange Commission at www.sec.gov.
CONTACT:
FMW Media Contacts: ? Bryan Johnson ? +1 (631) 766-7462 ? Bryan@NewToTheStreet.com
"New to The Street" Business Development Office ?1-516-696-5900 ?Support@NewToTheStreet.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/506703c3-e6ef-42c4-b1c1-4c683835c938
?
The 8-k should read, files on September 6, 2022 , rather than September 16. That’s a big mistake in the filings.
News out!!
The Sustainable Green Team Launches Unique Media Partnership With Accel Media International
NEW YORK, NY, Oct. 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- To change the conversation around sustainability and launch a nation-wide movement, The Sustainable Green Team LTD (OTCMKTS: SGTM) (“SGTM”) has partnered with Accel Media International LLC (“AMI”), to provide a bundle of media services including iconic billboards, short-form broadcasts, commercial and production guidance, media relations, and strategy planning and implementation. Short-form commercials highlighting SGTM and its sustainability message are expected to run across major news networks including Fox Business, Bloomberg, Newsmax and additional media outlets via AMI’s network of media partnerships.
Additionally, Accel Media International is expected to utilize New to the Street for Green Leader segments featuring SGTM’s Chief Executive Officer, Tony Raynor , which will be broadcast weekly on New to the Street’s Newsmax, Fox Business and Bloomberg-sponsored segments. Accel Media International is expected to provide press releases on SGTM segments featuring Raynor and his guests weekly.
“Our goal is to reduce the massive environmental burden of landfills by converting waste biomass into marketable environmentally conscious products,” Raynor said. “I am excited to partner with AMI on this one-of-a-kind media opportunity to show the country the importance of our unique sustainability solutions.”
The partnership is a first of its kind for AMI said Vince Caruso, AMI’s Chief Executive Officer. “AMI has worked with countless public and private organizations providing billboard, short-form media and access to our additional brand, New to the Street, and this partnership dwarfs previous deals,” Caruso said.
“The Sustainable Green Team and its unique environmental solutions has world-wide implications,” Caruso said. “We have committed more guaranteed media time and advertising options to SGTM than we have any other deal we’ve done. We expect that it will reach more than $30.7 million in media value over the next five years.”
?Raynor has played a major role in the green waste and arbor care industry for more than three decades. He founded The Sustainable Green Team to provide environmentally beneficial solutions in the tree care, disposal, and recycling industry. The company is a wholesale manufacturer and supplier of wood-based mulch, soil, and lumber products nationwide. The company also provides storm recovery services, and environmentally conscious green waste solutions to municipalities, corporations, and consumers in the United States.
It is this work that has led the company to be one of the leading eco-friendly companies in the nation, recycling, reusing and repurposing wood which can be found in thousands of everyday products.
“We are thrilled to partner with Accel Media to broadcast to millions of people weekly on The Sustainable Green Leader segments the unique value of recycling wood and other waste products,” Raynor said. “And by featuring other environmental innovators we will tell the stories of how companies across the globe are protecting our Earth for today and tomorrow.”
Another element to the unique relationship is the fact the two companies will partner to offer clients who appear on SGTM and others full production capabilities via its production arm Daydreamer Productions. These are 30-minute or one-hour long documentary style segments that may air on national broadcast outlets as well as be available for the client to utilize via their own channels.
“This unique partnership revolutionizes media and news,” Caruso said. “And to work with Tony and his innovative company to change the sustainability industry is a once-in-a-lifetime opportunity.”
“Partnering with Accel Media international is a major opportunity for us to continue with our goal” Raynor said. “We can’t do this alone. This is going to take a very big group of individuals working together to make a difference in our world.”
About Sustainable Green Team Ltd. (SGTM)
The Sustainable Green Team Ltd. (the “Company”) is a wholesale manufacturer and supplier of wood-based mulch, soil, and lumber products, selling directly to mass merchandisers, home centers, hardware stores, nurseries, garden centers, convenience stores, food stores and drug stores, in addition to wholesalers and distributors. The Company also provides arbor care and storm recovery services at the residential, commercial and municipal levels while offering green waste solutions to large and small scale waste disposal and recycling companies located throughout the southeastern United States. The Company’s subsidiary, Mulch Manufacturing Inc., is the largest provider of cypress mulch in the country.
The Company has entered into a partnership with Australia-based VRM Biologik Group to bring its world-leading soil moisture technology to the U.S.
HumiSoil® and XLR8 Bio® are soil treatment products that rebuild soil hydration on a cellular level, improving the soil and the vegetation and agricultural products it supports.
The Company will make HumiSoil and XLR8 Bio available for home gardens and lawns throughout the U.S. to help relieve water use in cities and also to help VRM Biologik Group in its mission to restore productivity in depleted topsoil in 25 percent of the world’s arable land.
To learn more, please visit thesustainablegreenteam.com, or vrmbiologik.com, or feel free to visit SGTM’s YouTube Channel.
About Accel Media International
AMI OUTDOOR, an Accel Media International company was formed in October 2019 to provide Out-Of-Home packages that include subway digital, street level, massive static and digital billboards. AMI operates placements in six markets and packages in addition to long-form broadcast interviews with assorted partners nationwide including the New to The Street business show.
FORWARD-LOOKING STATEMENTS: This release contains "forward-looking statements." Forward-looking statements also may be included in other publicly available documents issued by SGTM and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" and other words of similar meaning in connection with a discussion of future operating or financial performance.
Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.
Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause SGTM’s actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for SGTM’s products and services, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered with these factors in mind. We caution investors not to rely unduly on any forward-looking statements and urge you to carefully consider the risks described in our filings with the OTC Markets website at www.otcmarkets.com. We assume no obligation to update any forward-looking statements contained in this press release.
Contact:
info@nationalarborcare.com
?
I agree! .05 cents close today is my prediction.
Last week RXMD was up 16%, this past week RXMD is up another 17%. That’s a very bullish sign, if this pattern continues we should be trading near .08 by end of the month. Imo
With this high volume of trades this week, I would think Iliad will be exhausting it’s supply of dilution.
I would call this , the meeting of the WHALES. They will get the inner workings and prepare for investing in the near future.
And RXMD should break that 50 million revenue ceiling.
Share Share
Tweet Tweet
Forward Forward
Progressive Care Subsidiary ClearMetrX Launches 340MetrX Platform to Help Streamline 340B Program and Increase Claim Capture
See on website
MIAMI, FL – October 6, 2022 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce the launch of its 340Metrx Platform to help 340B covered entities increase the number of 340B qualified claims and program savings while supporting compliance efforts.
The 340MetrX platform is a software product developed by the Company’s wholly-owned subsidiary ClearMetrX that provides 340B-covered entities with data insights to effectively operate and maximize the benefits of the 340B program. The platform allows program administrators to manage, in real time, data related to revenue, virtual inventory, drug replenishment and reconciliation, detailed prescription history analysis, customized ordering data with major wholesalers, patient information, drug prescribing trends, and customized financial breakdowns. The software analyzes claim records and provides a complete overview of the financial health of the entity while diminishing the number of ineligible claims through the 340MetrX automated review process.
The 340MetrX software enhances the existing third-party administration services ClearMetrX is currently providing to entities by complementing in-house 340B experts with a robust reporting platform aiming to maximize the limited resources in the 340B space through identification and validation of missing claims, increasing the covered entity’s revenue.
“340MetrX allows our data analytics processes to be significantly more productive, giving our team an ability to seamlessly manage data for a much greater number of 340B entities in Florida, with potential to be scaled nationwide. According to data from Berkeley Research Group Industry Roundtable Report, 340B gross sales across the program are expected to grow from $116B in 2021 to $280B in 2026. We intend to take full advantage of the momentum this sector presents and are excited to now offer customers in every part of our country a solution that allows them to reduce efforts related to compliance and risk mitigation, strengthen the potential to capture more revenue, and simplify the whole 340B process” Stated Alan Jay Weisberg, CEO of Progressive Care Inc.
For more information about Progressive Care, please visit the Company’s website. Connect and stay in touch with us on social media:
Progressive Care Inc.
Progressivecareus.com
PharmCoRx Pharmacy
Pharmcorx.com
ClearMetrx
Clearmetrx.com
About Progressive Care
Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Forward-Looking Statements:
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
?
Find Out More
Facebook
Twitter
Link
Website
Copyright © 2022 Progressive Care, All rights reserved.
You are receiving this email because you opted in via our website.
Our mailing address is:
Progressive Care
901 North Miami Beach Blvd
Suite 1 and 2
North Miami Beach, FL 33162
Add us to your address book
Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.
Email Marketing Powered by Mailchimp
Yes I was in the same boat. They were moving in the right direction but they lacked the expertise. Now they have partnered with the expertise and I think will be able to achieve that milestone. When Jay was spouting off with these far out plans, I believe they were already in negotiations with Nexplat.
It looks very promising that RXMD will be trading in the .04 cents range next week.
RXMD is up 16+% for the week. Accumulate/Distr graph still going up. Great week, excited about what next week has in store.
It’s best you prepare for that now so you’re not overwhelmed when it does happen.
I can’t afford new clothes until we go through.10 cents. Maybe a new car at .20. We will get there sooner now with this partnership.
Great Bio. RXMD is in great hands. Thanks SF.
I only see a market trade of 5 shares. What does your MM show?
No solid information on what they are going to do with the company. Lots of vague wording. No mention of an attorney letter that was supposed to be issued last January. These guys are setting this up for much much more dilution. IMO
Hurricane IAN is going to be a nice paycheck for SGTM. It’s coming right through their backyard.
Some of the best CEOs started at the bottom.
????
Man you’re starting to think like a CEO. Lol